Lineage Cell Therapeutics Inc
TASE:LCTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lineage Cell Therapeutics Inc
TASE:LCTX
|
US |
Shareholder Yield
Current shareholder yield for LCTX is .
Peers Comparison
Shareholder Yield
Price Appreciation
LCTX Price
Lineage Cell Therapeutics Inc
| Average Annual Return | -28.5% |
| Standard Deviation of Annual Returns | 23.74% |
| Max Drawdown | -100% |
| Market Capitalization | 272.5m ILS |
| Shares Outstanding | 790 772 |
| Percentage of Shares Shorted |
N/A
|